In-Vitro Fertilization (IVF)
Submission Deadline: 31 Dec 2026
Guest Editor
Michael Dahan is on faculty in the Department of Obstetrics and Gynecology at McGill University. He graduated from medical school at the State University of New York at Stonybrook in 1996, Residency in obstetrics and gynecology at Long Island College Hospital in 2000 and a fellowship in reproductive endocrinology and infertility at the University of California at San Diego in 2003. Dr. Dahan has authored over 200 peer-reviewed publications and 200 abstracts and has been awarded over $1.3 million in research grants. He is a past Chair of the Associate Committee of the Society for Reproductive Endocrinology and Infertility (SREI). He has been invited to present nationally and internationally over 140 times. He is listed in Who is Who of Medicine. The name Dahan’s syndrome has been applied to pituitary injury due to vasospasm, which he first described in the medical literature. When he is not working, he enjoys traveling and spending time with his wife and five children.
Interests: assisted reproductive technology; obstetrics and gynecology
Special Issue in IMR Press journals
Special Issue Information
Dear Colleagues,
In-vitro fertilization has continuously gained in popularity since its first delivery in 1978. This is primarily due to women delaying childbirth later in life and the ease of availability of care in many nations. IVF has changed significantly over the years, starting with clomiphene for ovarian stimulation, followed by human menopausal gonadotropins then recombinant FSH and LH. Techniques have been developed to prevent ovarian hyperstimulation which was once common and has become rare. Preimplantation testing of the embryos can be done to prevent disease and may improve certain outcomes. Intracytoplasmic sperm injection has been used to overcome severe male factor infertility. We can freeze oocytes to prolong fertility later in life in cancer patients and in women without partners. Ingenuity in IVF continues with novel mechanisms to prevent ovulation being developed. We at Clinical and Experimental Obstetrics & Gynecology are developing an issue of our journal focused on novel IVF outcomes and the ingenuity in this field.
Assoc. Prof. Michael H. Dahan
Guest Editor
Keywords
- IVF
- IVM
- agonist trigger
- ovarian hyperstimulation syndrome
- progestins to prevent
- ovulation
- fertility preservation
- oocyte freezing
Published Papers (12)
Fertilization Following Short Maturation versus Intracytoplasmic Sperm Injection: A Comparative Study of Fertilization Outcomes in Sibling Oocytes from Women with Varying Stages of Endometriosis
Clin. Exp. Obstet. Gynecol. 2025, 52(6), 31346; https://doi.org/10.31083/CEOG31346
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
Progestin-Primed Ovarian Stimulation with Dydrogesterone Improves Oocyte and Embryo Outcomes in Women Undergoing Fertilization: A Randomized Controlled Study
Clin. Exp. Obstet. Gynecol. 2025, 52(4), 27951; https://doi.org/10.31083/CEOG27951
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
Does the Transfer of a Poor-Quality Embryo alongside a Good-Quality Embryo at the Cleavage or Blastocyst Stage Affect Pregnancy Rates? A Retrospective Cohort Study
Clin. Exp. Obstet. Gynecol. 2025, 52(3), 26381; https://doi.org/10.31083/CEOG26381
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
Effects of Uniform or Multi-Gradient Equilibration During Vitrification on Mitochondrial Damage in Mouse Oocytes
Clin. Exp. Obstet. Gynecol. 2025, 52(3), 27924; https://doi.org/10.31083/CEOG27924
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
Comparing Short and Long Oocyte-Sperm Co-Incubation Periods on in Vitro Developmental Outcomes
Clin. Exp. Obstet. Gynecol. 2024, 51(12), 267; https://doi.org/10.31083/j.ceog5112267
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
Relationship between Platelets, Plateletcrit and Lymphocytes in the Complete Blood Count and Recurrent Implantation Failure: A Retrospective Study
Clin. Exp. Obstet. Gynecol. 2024, 51(7), 149; https://doi.org/10.31083/j.ceog5107149
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
Which Ovarian Reserve Marker is More Reliable in IVF Patients with AMH and AFC Discordance?
Clin. Exp. Obstet. Gynecol. 2024, 51(2), 49; https://doi.org/10.31083/j.ceog5102049
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
Factors Associated with the Occurrence of 0PN Fertilization in in Vitro Fertilization and its Effects on Embryo Development and Reproductive Outcomes
Clin. Exp. Obstet. Gynecol. 2024, 51(2), 32; https://doi.org/10.31083/j.ceog5102032
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
Effect of SARS-CoV-2 Infection on IVF/ICSI-ET Outcomes: A Propensity Score-matched Cohort Study
Clin. Exp. Obstet. Gynecol. 2023, 50(12), 278; https://doi.org/10.31083/j.ceog5012278
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
Retrospective Analysis of Fresh Single Blastocyst Transfer versus Two Cleavage-Stage Fresh Day-3 Embryo Transfer with High-Quality Embryos during Gonadotropin-Releasing Hormone Antagonist Cycles in High Responders
Clin. Exp. Obstet. Gynecol. 2023, 50(11), 231; https://doi.org/10.31083/j.ceog5011231
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
Report of Two Cases of Pelvic Inflammatory Disease Complicating Transcervical Frozen Embryo Transfer
Clin. Exp. Obstet. Gynecol. 2023, 50(1), 20; https://doi.org/10.31083/j.ceog5001020
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))
A patient and physician friendly stimulation protocol using long acting FSH and progestin priming should be the future of IVF
Clin. Exp. Obstet. Gynecol. 2022, 49(3), 78; https://doi.org/10.31083/j.ceog4903078
(This article belongs to the Special Issue In-Vitro Fertilization (IVF))